US equities
|
MU
$953.19
▼-3.62%
NVDA
$228.52
▲+0.97%
META
$762.50
▲+2.63%
AAPL
$341.27
▲+0.09%
MSFT
$543.45
▲+0.43%
SNDK
$1,482.33
▼-0.34%
AMD
$605.53
▲+1.90%
SPCX
$156.54
▼-4.21%
MU
$953.19
▼-3.62%
NVDA
$228.52
▲+0.97%
META
$762.50
▲+2.63%
AAPL
$341.27
▲+0.09%
MSFT
$543.45
▲+0.43%
SNDK
$1,482.33
▼-0.34%
AMD
$605.53
▲+1.90%
SPCX
$156.54
▼-4.21%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Latest News about Immuno/Oncology
Recent news which mentions Immuno/Oncology
Alkermes Highlights Ongoing Investigational Immuno-oncology Clinical Trials
January 12, 2022
Tickers
ALKS
Tags
clinical research
Health & Healthcare
Alkermes
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Bolt Biotherapeutics Reveals Early Data From BDC-1001 Immuno-Oncology Candidate
December 06, 2021
Tickers
BOLT
Tags
General
Immuno/oncology
Movers
From
Benzinga
Gilead Wins Reversal of $1.2B Patent Loss to Bristol-Myers: Bloomberg
August 26, 2021
Tickers
BMY
GILD
Tags
News
Market News
BMY
From
Benzinga
iBio Expands Immuno-Oncology Pipeline With RubrYc Deal
August 25, 2021
Tickers
IBIO
Tags
Health Care
Briefs
Benzinga
From
Benzinga